Nebula Biochem Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.40 M
- Company Age 17 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 M
- Revenue Growth 9.90%
- Profit Growth 10.41%
- Ebitda 11.11%
- Net Worth 14.88%
- Total Assets 6.75%
About Nebula Biochem
Nebula Biochem Private Limited (NBPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 October 2007 and has a history of 17 years and three months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹1.50 M.
Sharada Pawar and Raghunath Pawar serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24110MH2007PTC175563
- Company No.
175563
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Oct 2007
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Nebula Biochem?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raghunath Pawar  | Managing Director | 31-Oct-2007 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sharada Pawar | Director | 31-Oct-2007 | Current |
Financial Performance of Nebula Biochem.
Nebula Biochem Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.9% increase. The company also saw a substantial improvement in profitability, with a 10.41% increase in profit. The company's net worth Soared by an impressive increase of 14.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nebula Biochem?
In 2023, Nebula Biochem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Avni Consumer Care Products Private LimitedRaghunath Pawar is a mutual person
Charges (Loans)
₹1.50 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Aug 2023 | Hdfc Bank Limited | ₹1.50 M | Open |
How Many Employees Work at Nebula Biochem?
Unlock and access historical data on people associated with Nebula Biochem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nebula Biochem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nebula Biochem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
